Rosalind Advisors, Inc.
Rosalind Advisors, Inc. reported 46 holdings worth US$312M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Rosalind Advisors, Inc. reported 46 holdings worth US$312M as of Sep 30, 2026. Largest: Delcath Systems, Inc., Verastem, Inc. and Fennec Pharmaceuticals Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 46
- Value as reported
- US$312M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Delcath Systems, Inc. | 3.3M | US$52.7M | 16.9% |
| Verastem, Inc. | 4.24M | US$34.1M | 10.9% |
| Fennec Pharmaceuticals Inc. | 3.19M | US$34M | 10.9% |
| Xeris Biopharma Holdings, Inc. | 2.58M | US$24.7M | 7.9% |
| Cybin, Inc. | 1.39M | US$17.1M | 5.5% |
| Savara, Inc. | 3.18M | US$16.4M | 5.3% |
| Replimune Group, Inc. | 1M | US$13.2M | 4.2% |
| Vor Biopharma Inc. | 609K | US$11.6M | 3.7% |
| X4 Pharmaceuticals, Inc. | 3.21M | US$9.32M | 3.0% |
| Aquestive Therapeutics, Inc. | 2M | US$9.26M | 3.0% |
| Vaxcyte, Inc. | 149K | US$8.5M | 2.7% |
| Protara Therapeutics, Inc. | 2.4M | US$7.32M | 2.3% |
| Myomo Inc. | 3.92M | US$6.11M | 2.0% |
| BioCryst Pharmaceuticals, Inc. | 722K | US$6.01M | 1.9% |
| Rocket Pharmaceuticals, Inc. | 2.2M | US$5.79M | 1.9% |
| PepGen Inc. | 2M | US$4.84M | 1.6% |
| Profound Medical Corp | 828K | US$4.8M | 1.5% |
| Talphera, Inc. | 4.13M | US$4.8M | 1.5% |
| NeurAxis, Inc. | 548K | US$4.04M | 1.3% |
| Ovid Therapeutics Inc. | 1.11M | US$2.76M | 0.88% |
| InspireMD Inc. | 3.91M | US$2.62M | 0.84% |
| Acumen Pharmaceuticals, Inc. | 1.1M | US$2.44M | 0.78% |
| EyePoint, Inc. | 696K | US$2.28M | 0.73% |
| Abivax SA | 20,869 | US$2.07M | 0.66% |
| Biofrontera Inc. | 1.79M | US$1.93M | 0.62% |
| Atea Pharmaceuticals, Inc. | 280K | US$1.46M | 0.47% |
| CG Oncology, Inc. | 20,000 | US$1.42M | 0.45% |
| Spruce Biosciences, Inc. | 26,517 | US$1.29M | 0.41% |
| Kura Oncology, Inc. | 100K | US$1.07M | 0.34% |
| Grace Therapeutics, Inc. | 476K | US$1.02M | 0.33% |
| OnKure Therapeutics, Inc. | 67,506 | US$184K | 0.06% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related